Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Operations

v3.7.0.1
Consolidated Statements of Operations and Comprehensive Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Income Statement [Abstract]    
Net sales $ 80,833 $ 80,746
Cost of sales [1] 57,046 56,214
Gross profit 23,787 24,532
Operating expenses:    
Marketing 10,314 10,794
General and administrative 4,801 4,433
Fulfillment 6,082 6,038
Technology 1,273 1,244
Amortization of intangible assets 112 112
Total operating expenses 22,582 22,621
Income from operations 1,205 1,911
Other income (expense):    
Other income, net 16 6
Interest expense (378) (347)
Total other expense, net (362) (341)
Income from continuing operations before income taxes 843 1,570
Income tax provision 27 33
Income from continuing operations 816 1,537
Discontinued operations    
Loss from operations and disposal of discontinued AutoMD operations [2] (558) (729)
Income tax provision (benefit) [2] 1 (182)
Loss on discontinued operations [2] (559) (547)
Net income 257 990
Other comprehensive loss:    
Foreign currency translation adjustments (2) (5)
Total other comprehensive loss (2) (5)
Comprehensive income $ 255 $ 985
Income from continuing operations per share:    
Basic net income from continuing operations per share (in USD per share) $ 0.02 $ 0.04
Diluted net income from continuing operations per share (in USD per share) $ 0.02 $ 0.04
Weighted average common shares outstanding:    
Shares used in computation of basic net income per share (in shares) 34,510 34,497
Shares used in computation of diluted net income per share (in shares) 39,959 39,359
[1] Excludes depreciation and amortization expense which is included in marketing, general and administrative and fulfillment expense.
[2] During March, 2017, AutoMD filed for dissolution and the AutoMD operating segment has been classified as discontinued operations.